Change - Announcement of Cessation::RESIGNATION OF EXECUTIVE DIRECTOR

Issuer & Securities

Issuer/ Manager
SINGAPORE O&G LTD.
Securities
SINGAPORE O&G LTD. - SG1DG2000005 - 1D8
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
30-Dec-2021 17:47:43
Status
New
Announcement Sub Title
RESIGNATION OF EXECUTIVE DIRECTOR
Announcement Reference
SG211230OTHRD8EU
Submitted By (Co./ Ind. Name)
Dr. Beh Suan Tiong
Designation
Executive Chairman
Description (Please provide a detailed description of the event in the box below)
This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document.

The contact person for the Sponsor is Ms. Jennifer Tan, 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318, sponsorship@ppcf.com.sg.

Additional Details

Name Of Person
Dr. Lee Keen Whye
Age
68
Is effective date of cessation known?
Yes
If yes, please provide the date
31/12/2021
Detailed Reason (s) for cessation
Dr. Lee Keen Whye ("Dr. Lee") tendered his resignation as Executive Director of the Company due to medical reasons. Dr. Lee remains as a Specialist Medical Practitioner of the SOG Group.

After having interviewed Dr. Lee and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that save as disclosed in this announcement, there are no other material reasons for the resignation of Dr. Lee as Executive Director of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
06/01/2011
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
2
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director
Role and responsibilities
Executive
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Direct interest - 75,600,356
(15.9% of total no. of ordinary shares)

Deemed interest - 6,104,524
(1.28% of total no. of ordinary shares)
Past (for the last 5 years)
Nil
Present
1) K W Lee Clinic & Surgery Pte. Ltd.
2) Beh's Clinic For Women Pte. Ltd.
3) Choo Wan Ling Women's Clinic Pte. Ltd.
4) Heng Clinic For Women Pte. Ltd.
5) SOG Children (Paediatrics Central) Pte. Ltd.
6) SOG Children (Paediatrics-Gastroenterology Liver) Pte. Ltd.
7) SOG Children (Paediatrics-Gleneagles) Pte. Ltd.
8) SOG Dermatology (Gleneagles) Pte. Ltd.
9) SOG-Cindy Pang Clinic For Women Pte. Ltd.
10) SOG-Clara Ong Clinic For Women Pte. Ltd.
11) SOG-HL Sim Colorectal, Endoscopy & General Surgery Pte. Ltd.
12) Avesa Pte Ltd
13) Clover Mum Pte. Ltd.
14) Lee & Lee Clinic Pte Ltd
15) Singa Hospitality Pte. Ltd.
16) Singa Hotel Development Pte. Ltd.
17) Singa Hotel Nagoya Pte. Ltd.
18) Singa Management Pte. Ltd.
19) Singa Project Development Pte. Ltd.
20) Singa Realty Pte. Ltd.
21) Singa SV Investment Pte. Ltd.
22) Singa Wealth Pte. Ltd.
23) 3LA-HK Pte. Ltd.
24) 3LA-SB Pte. Ltd.
25) 3LA-SU Pte. Ltd.